Skip to main content
. 2020 May 22;21(10):3655. doi: 10.3390/ijms21103655

Table 2.

Relationship between SRPX2 Expression and Clinicopathological Parameters.

SRPX2 Expression
Parameters − (%) + (%) p Value *
Gender
Male 61 (68.5) 28 (31.5)
Female 55 (76.4) 17 (23.6) 0.2938
Age
<65 54 (75) 18 (25)
>65 62 (69.7) 27 (30.3) 0.4844
Site
Tongue 60 (66.7) 30 (33.3)
Gingiva 42 (80.8) 10 (19.2)
Buccal mucosa 7 (70) 3 (30)
Other 7 (77.8) 2 (22.2) 0.3305
Histology
Well 57 (75) 19 (25)
Moderately, Poorly 59 (69.4) 26 (30.6) 0.4839
T classification
T1-T3 81 (74.3) 28 (25.7)
T4 35 (67.3) 17 (32.7) 0.3554
Clinical stage
I-II 79 (75.2) 26 (24.8)
IV 37 (66.1) 19 (33.9) 0.2688
Nodal metastasis
Negative 91 (77.1) 27 (22.9)
Positive 25 (58.1) 18 (41.9) 0.0280
MVD 25.128 ± 14.741 33.109 ± 23.841 0.0111
LVD 20.245 ± 13.894 27.136 ± 19.583 0.0129

The relationship between expression of sushi repeat containing protein X linked-2 (SRPX2) and each factor was calculated by Fisher’s exact test or chi-square test. The differences of the microvessel density (MVD) and lymphovessel density (LVD) among groups were analyzed by unpaired parametric t-test. MVD and LVD were Means ± S.D. (standard deviation), each S.D. was less than 10% in all cases. T classification and clinical stage were classified according to the TNM classification.* p value < 0.05 was regarded as statistically significant.